Phoenix Financial’s Gilead Sciences GILD Stock Holding History

Phoenix Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Buy	20,279 +8,155	+67%	+$1.14M	0.03%	150
2025 Q4	$1.49M	Buy	12,124 +963	+9%	+$117K	0.02%	203
2025 Q3	$1.24M	Buy	11,161 +1,067	+11%	+$121K	0.02%	212
2025 Q2	$1.12M	Buy	10,094 +564	+6%	+$60K	0.01%	225
2025 Q1	$1.07M	Buy	9,530 +5,585	+142%	+$576K	0.02%	209
2024 Q4	$364K	Sell	3,945 -13,079	-77%	-$1.18M	0.01%	292
2024 Q3	$1.43M	Buy	+17,024	New	+$1.3M	0.02%	203
2020 Q4	–	Sell	-31,114	Closed	-$1.82M	–	388
2020 Q3	$1.82M	Buy	31,114 +3,098	+11%	+$215K	0.08%	164
2020 Q2	$1.99M	Sell	28,016 -13,675	-33%	-$1.05M	0.08%	160
2020 Q1	$3.03M	Sell	41,691 -138,162	-77%	-$9.55M	0.15%	128
2019 Q4	$11.6M	Sell	179,853 -70,547	-28%	-$4.59M	0.49%	77
2019 Q3	$15.1M	Buy	+250,400	New	+$16.4M	0.72%	63

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Phoenix Financial's GILD Position: Q1 2026 in Review

Phoenix Financial increased its Gilead Sciences (GILD) stake by 67% in Q1 2026, buying an estimated $1.14M and bringing the position to 20,279 shares worth $2.83M. The position accounts for 0.03% of the portfolio, ranked #150.

Phoenix Financial first reported a position in GILD in Q3 2019 and has held it in 12 quarters since. The position peaked at $15.1M in Q3 2019. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Phoenix Financial held 20,279 shares of Gilead Sciences worth $2.83M as of Q1 2026.
Phoenix Financial bought 8,155 Gilead Sciences shares in Q1 2026, an estimated $1.14M.
Gilead Sciences made up 0.03% of Phoenix Financial's portfolio in Q1 2026, its #150 holding.
Phoenix Financial first reported a position in Gilead Sciences in Q3 2019 and has held it in 12 quarters since.
Phoenix Financial's Gilead Sciences position peaked at $15.1M in Q3 2019.
2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.